Latest CAH news

Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term

Zacks Investment Research · Wed, 23 Sep 2026 10:45:52 -0400

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?

Zacks Investment Research · Tue, 22 Sep 2026 10:36:03 -0400

CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.

Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?

Zacks Investment Research · Tue, 22 Sep 2026 10:36:02 -0400

CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.

Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?

Zacks Investment Research · Tue, 22 Sep 2026 10:30:55 -0400

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks Investment Research · Mon, 21 Sep 2026 09:56:06 -0400

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds

MarketBeat · Sat, 19 Sep 2026 18:02:42 -0400

Cardinal Health NYSE: CAH CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what he described as a “constructive” period.

Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand

MarketBeat · Sat, 19 Sep 2026 12:02:22 -0400

Cardinal Health NYSE: CAH CEO Jason Hollar said the company's fiscal 2026 performance was supported by double-digit earnings growth across each of its five operating segments, while fiscal 2027 guidance reflects continued growth from a more normalized base.

Market information is provided for research and visualization and is not investment advice.